InSpecs Group navigates financial dip with new chair appointment and optimistic outlook
InSpecs Group has reported its first-half results, revealing a period of financial weakness for the first six months of the year. However, the eyewear manufacturer also shared positive news regarding its leadership, confirming the successful completion of its search for a non-executive chair.
The company, known for producing eyewear under its own brands and licensed names such as Barbour, Joseph, Radley, Superdry, Temperley, and Viktor&Rolf, had previously flagged these results in July. On Thursday, InSpecs Group announced a revenue decline to £97.6 million, down from £100.6 million in the prior year. On a constant currency basis, the dip was less pronounced, falling by 1.3% to £99.3 million. Financial metrics also showed a contraction in the gross profit margin by 80 basis points to 51.8%, while underlying EBITDA decreased to £9 million from £11 million, largely due to the revenue decline. Profit before tax also saw a slight reduction, moving from £2.6 million to £2.4 million.
Despite the challenging first half, InSpecs Group expressed an upbeat outlook for its future prospects. While trading in the first two months of H2 has been slightly behind plan, the company anticipates a stronger performance in the remainder of the year, driven by growth in its order books and increased cost savings. A notable success cited was the "successful" launch of the Tom Tailor eyewear brand on July 1st, with initial sales already ahead of target.
Operational efficiencies continue to be a key focus, with the company achieving a £1.1 million reduction in operating expenses within its Frames and Optics division in H1 2025 compared to H1 2024. Further rationalisation efforts across the group are underway, including the discontinuation of Norville, its loss-making lens manufacturing site, which is expected to bolster future profitability. The amalgamation of selected European sales businesses is also proceeding as planned, with completion anticipated by the end of 2025.
However, InSpecs Group continues to navigate external headwinds. Ongoing tariff disruptions persist, affecting its manufacturing exports from China to the US. Additionally, the US optics division has been impacted by reduced government expenditure on low vision services, attributed to changes in the political landscape.
In a significant leadership update, the company announced that Andrea Davis will join as its new non-executive chair on or before December 31st. Davis brings extensive experience, having chaired and advised a diverse range of assets across consumer, manufacturing, and other sectors, primarily within small to mid-cap companies across continental Europe. She currently serves on the boards of Modulr and William Jackson Food Group and recently held the position of MD of European Private Equity at Investcorp. Interim chair Christopher Hancock remarked, “Andrea has a proven track record in business strategy and transformation and her experience in supporting UK and international companies through their growth journeys will be invaluable to InSpecs Group.”
